Intrinsic Value of S&P & Nasdaq Contact Us

Nuvalent, Inc. NUVL NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
57/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$137.44
+30.9%

There have been 50 recent insider transactions recorded for Nuvalent, Inc. (NUVL), including 14 buys and 34 sells. Total insider buying was valued at $9.81M and total insider selling at $8.01M.

Notable insiders with recent activity include Lane Benjamin, Balcom Alexandra, Noci Darlene. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — NUVL

Date Name Role Transaction Shares Avg. Price Value Shares Owned
2026-04-01 Lane Benjamin See Remarks RSU Award 19,000 $105.64 $2.01M 19,000
2026-04-01 Balcom Alexandra Chief Financial Officer Informative Sell 2,469 $106.18 $262.16K 85,533
2026-03-30 Noci Darlene Chief Development Officer Informative Sell 2,968 $98.13 $291.25K 58,117
2026-03-26 Miller Deborah Ann Chief Legal Officer Informative Sell 2,803 $99.46 $278.79K 59,634
2026-03-25 Balcom Alexandra Chief Financial Officer Informative Sell 13,700 $100.16 $1.37M 85,533
2026-03-24 Balcom Alexandra Chief Financial Officer Informative Sell 1,160 $96.50 $111.94K 99,233
2026-03-16 Lane Benjamin See Remarks Unknown 12,025 $78.09 $939.03K -
2026-03-13 Pelish Henry E. Chief Scientific Officer Informative Sell 1,703 $99.71 $169.81K 65,604
2026-03-12 Pelish Henry E. Chief Scientific Officer Option Exercise (Sell) 8,456 $18.93 $160.07K 2,113
2026-03-06 Porter James Richard President and CEO Option Exercise (Sell) 30,000 $27.85 $835.5K 147,780
2026-02-26 Noci Darlene Chief Development Officer Informative Sell 200 $104.25 $20.85K 58,117
2026-02-26 Miller Deborah Ann Chief Legal Officer Informative Sell 200 $103.96 $20.79K 59,634
2026-01-29 Noci Darlene Chief Development Officer Informative Sell 63 $103.39 $6.51K 58,117
2026-01-22 Miller Deborah Ann Chief Legal Officer Informative Sell 14,300 $110.16 $1.58M 59,634
2026-01-21 Miller Deborah Ann Chief Legal Officer Informative Sell 700 $109.84 $76.89K 59,634
2026-01-07 Turner Christopher Durant Chief Medical Officer RSU Award 17,500 - - 72,630
2026-01-07 Noci Darlene Chief Development Officer RSU Award 17,500 $106.82 $1.87M 17,500
2026-01-07 Miller Deborah Ann Chief Legal Officer RSU Award 17,500 $106.82 $1.87M 17,500
2026-01-07 Pelish Henry E. Chief Scientific Officer RSU Award 17,500 $106.82 $1.87M 17,500
2026-01-06 Noci Darlene Chief Development Officer Informative Sell 225 $98.40 $22.14K 40,617
2026-01-06 Miller Deborah Ann Chief Legal Officer Informative Sell 183 $98.40 $18.01K 42,134
2026-01-06 Pelish Henry E. Chief Scientific Officer Informative Sell 189 $98.40 $18.6K 65,888
2026-01-05 Turner Christopher Durant Chief Medical Officer Informative Sell 1,119 $96.85 $108.38K 60,557
2026-01-05 Noci Darlene Chief Development Officer Informative Sell 317 $98.52 $31.23K 43,798
2026-01-05 Miller Deborah Ann Chief Legal Officer Informative Sell 326 $98.52 $32.12K 44,723
2026-01-05 Pelish Henry E. Chief Scientific Officer Informative Sell 186 $98.52 $18.32K 68,552
2025-06-18 Protopapas Anna Director RSU Award 4,147 $75.53 $313.22K 4,147
2025-06-18 Flynn James E 10 Percent Owner, Other: Director By Deputization RSU Award 2,647 - - 2,647
2025-06-18 Srivastava Sapna Director RSU Award 4,147 $75.53 $313.22K 4,147
2025-06-18 Bogle Grant C. Director RSU Award 4,147 $75.53 $313.22K 4,147
2025-06-18 Meyers Michael L. Director RSU Award 4,147 $75.53 $313.22K 4,147
2025-06-18 Wheeler Cameron Director RSU Award 4,147 $75.53 $313.22K 4,147
2025-06-18 Oliger Christy J. Officer Unknown - - - -
2025-06-18 Oliger Christy J. Director RSU Award 3,971 - - 3,971
2025-06-18 Shair Matthew Director RSU Award 4,147 $75.53 $313.22K 4,147
2025-06-18 Pearlberg Joseph Director RSU Award 4,147 $75.53 $313.22K 4,147
2025-06-16 Porter James Richard President and CEO Option Exercise (Sell) 27,000 $27.85 $751.95K 177,780
2025-06-06 Pelish Henry E. Chief Scientific Officer Option Exercise (Sell) 100 $29.33 $2.93K 32,075
2025-05-29 Noci Darlene Chief Development Officer Option Exercise (Sell) 2,129 $14.40 $30.66K 21,259
2025-05-15 Porter James Richard President and CEO Option Exercise (Sell) 27,000 $27.85 $751.95K 204,780
2025-04-29 Noci Darlene Chief Development Officer Option Exercise (Sell) 4,000 $14.40 $57.6K 23,388
2025-04-15 Porter James Richard President and CEO Option Exercise (Sell) 27,000 $27.85 $751.95K 231,780
2025-03-27 Noci Darlene Chief Development Officer Option Exercise (Sell) 1,773 $14.40 $25.53K 27,388
2025-03-17 Porter James Richard President and CEO Informative Sell 601 $76.69 $46.09K 249,062
2025-03-07 Noci Darlene Chief Development Officer Option Exercise (Sell) 4,000 $1.08 $4.32K 10,216
2025-03-06 Noci Darlene Chief Development Officer Option Exercise (Sell) 8,015 $6.89 $55.22K 6,776
2025-02-24 Shair Matthew Director Informative Sell 302 $79.13 $23.9K 216,522
2025-02-18 Porter James Richard President and CEO Informative Sell 800 $79.01 $63.21K 249,062
2025-01-31 Pelish Henry E. Chief Scientific Officer Option Exercise (Sell) 3,120 $0.87 $2.71K 2,007
2025-01-27 Shair Matthew Director Informative Sell 108 $85.00 $9.18K 218,522
Informative Buy/Sell — open market transaction (most significant) Uninformative Buy — award, option exercise, conversion Uninformative Sell — tax withholding, award vest sale Neutral — gift, trust, expiry
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message